A SPECT study using an [123I]IBVM ligand found that VAChT levels are significantly lower in the thalamus and anterior cingulate cortex of PSP patients compared to healthy controls, and that thalamic cholinergic dysfunction is inversely correlated with disease duration [29]. This evidence concerns the gene SLC18A3 and supranuclear palsy, progressive, 1.